Physicians Formula and Markwins International announced on Thursday that they have entered into a merger agreement under which Markwins will acquire all of the outstanding shares of common stock of Physicians Formula for $4.90 per share in cash, or approximately $74.9 million.

As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


Yellow Wood Partners has acquired mass market fragrance provider Parfums de Coeur, whose brands include Body Fantasies, Designer Imposters and BOD Man.

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

BioScrip on Wednesday posted $155.9 million in second-quarter revenue, up 18.5% compared with the prior year.

Beiersdorf’s Nivea brand has announced the launch of its first-ever Nivea "Kiss of Style" design contest, which will give one winner the opportunity to design a limited-edition cap for Nivea Lip Care that will be sold in stores.

An Ahold USA executive has received honors from a New England business publication.

A division of Nestle has bought a stake in a Colorado-based drug maker focused on treatments for neurodegenerative diseases.

Jel Sert has acquired three functional beverage brand names from Solis Brands.

Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.